
Eden Review
Best for: mainstream telehealth GLP-1 access
Premium telehealth platform with promotional first-month pricing on both semaglutide and tirzepatide.
then $239/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Eden is a solid telehealth option with balanced features and pricing.
Eden at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $189/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Eden
Each dimension is scored algorithmically from Eden’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.5/10At $239/mo, Eden runs about 41% above the $170 median for GLP-1 providers, and the first-month promo drops to $189. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.0/10Eden offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.8/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
8.0/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
8.2/10Eden treats patients in all 50 states.
Support10%
5.8/10Eden provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Eden review
Last checked 2026-06-03- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Eden offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Eden's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Eden: a flat-rate way into compounded GLP-1s in all 50 states
Eden (tryeden.com) is a mainstream telehealth platform built around one simple promise: the same price for every dose. Where many programs raise your bill as your dose climbs, Eden charges a flat monthly rate that doesn't change as you titrate up. It carries both semaglutide and tirzepatide in compounded form, runs a first-month promo on each, and says it can serve GLP-1 patients in all 50 states. If you want broad access and a predictable bill, Eden is worth a look — with a couple of honest caveats we'll get to.
How the pricing actually works
Eden uses a flat-dose model. Compounded semaglutide starts around $189 for your first month and settles at $239 monthly after that; compounded tirzepatide runs higher, with its own intro rate the first month. The flat structure is the real selling point here — your price is locked to the medication and form, not to how many milligrams you're injecting, so moving up the dose ladder over time doesn't quietly inflate your bill. For comparison, the category median sits near $170 a month, so Eden's ongoing semaglutide rate lands a bit above the middle of the pack but its first-month promo brings the entry cost down.
One thing to confirm before you commit: what the headline price actually covers. Eden's own materials say the price includes medication only, and that free expedited shipping comes with every order. But its pages have sent mixed signals about whether a provider visit and any membership component are bundled in or billed separately. Read the checkout screen carefully so you know whether you're paying for medication alone or medication plus a recurring membership.
A real pricing caveat
Be aware that Eden's live, on-site pricing has drifted from older published figures, and the company has at times shown a separate membership fee layered on top of the medication cost. The numbers above reflect our verified record, but Eden is exactly the kind of provider where you should price out the full first-month and ongoing total — medication, shipping, visit, and any membership — directly on its site before you enroll. Don't assume the sticker price is the whole bill.
The medications and how they're dispensed
Eden focuses on compounded GLP-1s — the two heavyweights for weight management, semaglutide and tirzepatide. Compounded means the medication is mixed by a pharmacy rather than supplied as a brand-name pen, which is how Eden keeps the monthly cost well under brand list prices that can run over a thousand dollars a month elsewhere. Medication ships to your door with free expedited shipping, so there's no pharmacy pickup.
- Compounded semaglutide — the same active ingredient as Ozempic and Wegovy
- Compounded tirzepatide — the dual-action molecule behind Mounjaro and Zepbound
- Flat monthly pricing that doesn't rise as your dose increases
- Free expedited shipping included on every order
What sets Eden apart — and where it falls short
Eden's genuine differentiators are nationwide reach and dose-proof pricing. Carrying both major GLP-1 molecules with a flat rate across all 50 states is a real convenience, especially if you expect to titrate up over many months and don't want your cost creeping with each step. That predictability is the main reason to choose it.
The flip side is transparency. Eden publishes comparatively little detail about the nuts and bolts of its program — and our record lists no named, accredited compounding pharmacy partner for it. That's a meaningful gap. The best compounded-GLP-1 providers tell you exactly which 503A/503B pharmacy mixes their medication and publish its accreditation; Eden leaves more of that behind the signup wall. There's no FDA warning on file for Eden, which is reassuring, but the thin public disclosure means you're taking more on trust than you would with a provider that lays everything out up front.
Who should choose Eden — and who should skip it
Eden is a good fit if you live somewhere other programs don't serve, want both semaglutide and tirzepatide on the menu, and value a flat bill that won't balloon as your dose rises. It's a sensible mainstream on-ramp to compounded GLP-1 therapy.
Skip it, or at least shop around first, if pharmacy transparency is a priority for you — if you want to know the exact compounding pharmacy and its accreditation before you pay. Also pause if surprise fees bother you: because Eden's live pricing and membership structure have shifted, you'll want to verify the all-in total yourself rather than rely on any single advertised number. And if you specifically need a brand-name pen, Eden's compounded-only lineup won't cover you.
Trust, safety, and medical oversight
Eden operates as a licensed telehealth platform serving all 50 states, with treatment requiring a clinician's prescription. There are no FDA warning letters on file for it, which is a positive baseline. Our confidence in Eden is moderate rather than high: the program is real and verified live, but the limited public detail on its pharmacy partner and the recent drift in its published pricing keep it from earning top marks on transparency. You can read how we weigh these factors in our scoring methodology.
The bottom line
Eden delivers wide access and a refreshingly predictable, dose-proof price on both leading GLP-1 medications, with shipping included and a first-month promo to soften the entry cost. The trade-off is transparency — thin program detail, no named accredited pharmacy in our record, and pricing that has moved around. Treat the advertised rate as a starting point, confirm the full all-in cost on Eden's own checkout, and it can be a solid, nationwide choice for compounded semaglutide or tirzepatide.
If you're weighing alternatives, Enhance MD ($212/month) and Direct Meds ($249/month) are among the closest options we track to Eden.
Ready to start with Eden?
Starting at $189/month. See current pricing and start your free consultation.
Alternatives to Eden
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Eden review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Eden?
Starting at $189/month. See current pricing and start your free consultation.